Novartis appoints Rob Kowalski as Chief People & Organization Officer

Novartis appoints Rob Kowalski as Chief People & Organization Officer

Novartis announced today the appointment of Rob Kowalski, Pharm.D., Global Head Regulatory Affairs, and US Head of Drug Development as Chief People & Organization Officer. He will report to Vas Narasimhan, M.D., CEO of Novartis, and become a member of the Executive Committee of Novartis (ECN), effective September 1, 2021. Currently Chief People & Organization…